Soligenix Inc (SNGX)
$1.97
0.08 (3.90%)
Why Is Soligenix (SNGX) Stock Down 27% Today?
Soligenix (SNGX) stock is falling hard on Tuesday with heavy trading after the company's HyBryte cancer drug was rejected by the FDA.
11 Best Stocks to Buy for 2023

INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
85.16M
PE Ratio
-5.63
EPS
-0.35
Volume (Avg. Vol.)
25,214
Day's Range
$1.84 - $2.04
52-Week Range
$1.75 - $15.00
Dividend & Yield
N/A (N/A)